Rheb1 cooperated with MLL-AF9 to promote acute myeloid leukemia progression, and deletion of Rheb1 in the MLL-AF9 acute myeloid leukemia mouse model prolonged the survival of mice by inhibiting the mTORC1 signaling pathway (Gao et al., 2016). Here, KMT2A is linked to acute myeloid leukemia.